G71142DF

Summary
GlyTouCan ID
G71142DF
IUPAC Condensed
Glc(b1-
Motifs
Glucosylceramide
GlyGen
ChEBI
PubChem Compound
PubChem Substance
The Human Metabolome Database
3D Structures
GlycoNAVI
G71142DF
GLYCAM
DGlcpb1-OH
GlycoShape
G71142DF
Displaying 1 entry
Archetype α β
G80753ZP
G58161NS
G71142DF
Organisms
Displaying entries 6 - 7 of 7 in total
Organisms Evidence
Nymphaeaceae
Chloroflexus aurantiacus J-10-fl
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying all 4 entries
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
B4GALT5 (not applicable)
G71142DF
Ceramide
G84224TW
Ceramide
B4GALT6 UDP-Gal
G71142DF
Cer
G84224TW
Cer
GXYLT1 UDP-Xyl
G71142DF
Ser
G01629YL
Ser
GXYLT2 UDP-Xyl
G71142DF
Ser
G01629YL
Ser
Displaying entries 6 - 9 of 9 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
B3GALT1 UDP-Gal
G71142DF
Cer
G31761VE
Cer
B4GALT3 UDP-Gal
G71142DF
[beta]1-Cer
G84224TW
[beta]1-Cer
GXYLT1 UDP-Xyl
G71142DF
Ser
G01629YL
Ser
GXYLT2 UDP-Xyl
G71142DF
Ser
G01629YL
Ser
Displaying entries 1 - 5 of 14 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Reference
B4GALT7 UDP-Gal
G71142DF
4-D-MethylUmb-[beta]
B3GALT4 UDP-Gal
G71142DF
Cer
B4GALNT4 UDP-GalNAc
G71142DF
[beta]-pNP
B4GALNT3 UDP-GalNAc
G71142DF
[beta]-pNP
B3GALNT2 UDP-GalNAc
G71142DF
[beta]-pNP
Pathway
Displaying entries 1 - 10 of 38 in total
Pathway Name Organism
E.coli O102 Escherichia coli
E.coli O103 Escherichia coli
E.coli O130 Escherichia coli
E.coli O134 Escherichia coli
E.coli O137 Escherichia coli
E.coli O139 Escherichia coli
E.coli O141 Escherichia coli
E.coli O150 Escherichia coli
E.coli O152 Escherichia coli
E.coli O157 Escherichia coli
Sequence Descriptors
GlycoCT
RES
1b:b-dglc-HEX-1:5
WURCS
WURCS=2.0/1,1,0/[a2122h-1b_1-5]/1/
Literature
Displaying entries 211 - 220 of 2845 in total
PubMed ID Title First Author Publication Date Source
33536238 Structural comparison of GLUT1 to GLUT3 reveal transport regulation mechanism in sugar porter family Custódio TF 2021 Feb 03
  • PubChem
33246032 Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP) Ho JD 2021 Feb
  • PubChem
34971447 Optimized isolation of 7,7′-biphyscion starting from Cortinarius rubrophyllus, a chemically unexplored fungal species rich in photosensitizers Hammerle F 2021 Dec 31
  • PubChem
34950974 Antagonistic activity and characterization of indigenous soil isolates of bacteria and fungi against onion wilt incited by Fusarium sp. Karim H 2021 Dec 23
  • PubChem
34728215 Structure of a bacterial α-1,2-glucosidase defines mechanisms of hydrolysis and substrate specificity in GH65 family hydrolases Nakamura S 2021 Dec
  • PubChem
34423383 An in vitro cytotoxicity of glufosfamide in HepG2 cells relative to its nonconjugated counterpart Ahmed DE 2021 Aug 23
  • PubChem
34370148 Characterization of β-glucosidase of Lactobacillus plantarum FSO1 and Candida pelliculosa L18 isolated from traditional fermented green olive Rokni Y 2021 Aug 09
  • PubChem
34363172 Metabolic and transcriptional disruption of American shad (Alosa sapidissima) by enrofloxacin in commercial aquaculture Du J 2021 Aug 07
  • PubChem
34363150 Preparation of Aspergillus niger 426 naringinases for debittering citrus juice utilization of agro-industrial residues de Oliveira F 2021 Aug 07
  • PubChem
34394766 Biological contaminants in the indoor air environment and their impacts on human health Kumar P 2021 Aug 07
  • PubChem

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.2.1

Last updated: April 7, 2025